| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/10/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 80.1k | $0.00 | $0 | | 05/09/2023 |
| 05/09/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 76.5k | $0.00 | $0 | | 05/09/2023 |
| 05/03/2023 | Philip Morris International Inc. | PM | Grant | Common Stock | 1.8k | $96.58 | $175k | | 05/03/2023 |
| 05/09/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 80.1k | $0.00 | $0 | | 05/08/2022 |
| 05/08/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 35.4k | $0.00 | $0 | | 05/08/2022 |
| 05/04/2022 | Philip Morris International Inc. | PM | Grant | Common Stock | 1.8k | $99.53 | $175.1k | | 05/04/2022 |
| 09/22/2021 | W R GRACE & CO | GRA | Disposition | Common Stock, par value $0.01 per share | 7k | $0.00 | $0 | | 09/22/2021 |
| 05/06/2021 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 46.2k | $0.00 | $0 | | 05/05/2021 |
| 05/05/2021 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 35.4k | $0.00 | $0 | | 05/05/2021 |
| 05/05/2021 | Philip Morris International Inc. | PM | Grant | Common Stock | 1.8k | $95.18 | $175k | | 05/05/2021 |
| 12/15/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 7.5k | $0.00 | $0 | | 12/15/2020 |
| 05/12/2020 | W R GRACE & CO | GRA | Grant | Common Stock, par value $0.01 per share | 2.3k | $0.00 | $0 | | 05/12/2020 |
| 05/05/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 46.2k | $0.00 | $0 | | 05/05/2020 |
| 12/14/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 28.5k | $4.76 | $135.7k | | 12/14/2019 |
| 12/14/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 7.5k | $0.00 | $0 | | 12/14/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy | 2.8k | $40.06 | $110.8k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 2k | $53.70 | $106.3k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 1.6k | $58.98 | $93k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 1.6k | $45.12 | $72.8k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 2.1k | $41.23 | $88.2k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 3.9k | $21.70 | $83.8k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 6.4k | $12.90 | $82.2k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Sale | Common Stock | 35.8k | $60.00 | $2.1M | | 12/04/2019 |
| 06/20/2019 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 126k | $3.00 | $378.2k | | 06/20/2019 |
| 05/08/2019 | W R GRACE & CO | GRA | Grant | Common Stock, par value $0.01 per share | 1.5k | $0.00 | $0 | | 05/08/2019 |
| 04/24/2019 | CAMBREX CORP | CBM | Grant | Common Stock | 2.2k | $0.00 | $0 | | 04/24/2019 |
| 04/24/2019 | CAMBREX CORP | CBM | Grant | Stock Option (right to buy) | 2.8k | $40.06 | $110.8k | | 04/24/2019 |
| 06/08/2018 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 54.3k | $2.76 | $150k | | 06/08/2018 |
| 05/09/2018 | W R GRACE & CO | GRA | Grant | Common Stock, par value $0.01 per share | 1.5k | $0.00 | $0 | | 05/09/2018 |
| 04/26/2018 | CAMBREX CORP | CBM | Grant | Common Stock | 1.4k | $0.00 | $0 | | 04/26/2018 |
| 04/26/2018 | CAMBREX CORP | CBM | Grant | Stock Option (right to buy) | 2k | $53.70 | $106.3k | | 04/26/2018 |
| 07/12/2017 | Exela Technologies, Inc. | XELA | Disposition | Common Stock | 29.5k | $0.00 | $0 | | 07/12/2017 |
| 08/29/2016 | Sagent Pharmaceuticals, Inc. | SGNT | Disposition | Common Stock | 742 | $21.75 | $16.1k | | 08/29/2016 |
| 08/29/2016 | Sagent Pharmaceuticals, Inc. | SGNT | Disposition | Restricted Stock Units | 8.6k | $21.75 | $186.1k | | 08/29/2016 |
| 08/29/2016 | Sagent Pharmaceuticals, Inc. | SGNT | Disposition | Restricted Stock Units | 2.2k | $21.75 | $48.5k | | 08/29/2016 |
|